These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Sorptive properties of medicinal charcoal. VI. Suspensions of medicinal charcoal]. Pawlaczyk J; Sobczak H Acta Pol Pharm; 1981; 38(5):617-9. PubMed ID: 7342700 [No Abstract] [Full Text] [Related]
5. Container residue after the administration of aqueous activated charcoal products. Krenzelok EP; Lush RM Am J Emerg Med; 1991 Mar; 9(2):144-6. PubMed ID: 1994942 [TBL] [Abstract][Full Text] [Related]
6. Correlative studies of the hypocholesterolemic effect of a highly activated charcoal. Tishler PV; Winston SH; Bell SM Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):799-806. PubMed ID: 3441164 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of commercially available aqueous activated charcoal products. Krenzelok EP; Heller MB Ann Emerg Med; 1987 Dec; 16(12):1340-3. PubMed ID: 3688595 [TBL] [Abstract][Full Text] [Related]
8. Container residue of activated charcoal products. Harchelroad F Am J Emerg Med; 1991 Sep; 9(5):520. PubMed ID: 1863306 [No Abstract] [Full Text] [Related]
9. Enhanced activated charcoal delivery through small-bore tubing. Schneider SM; Michelson EA Vet Hum Toxicol; 1993 Dec; 35(6):503-5. PubMed ID: 8303817 [TBL] [Abstract][Full Text] [Related]
10. Preparation and performance of cross-linked agar encapsulated activated charcoal (CAAC-III). Chen YM; Tang XJ; Xu CX; Li ZM J Microencapsul; 1991; 8(3):327-34. PubMed ID: 1941439 [TBL] [Abstract][Full Text] [Related]
11. Sucrose as a sweetener for activated charcoal. Cooney DO; Roach M Am J Hosp Pharm; 1979 Jun; 36(6):797-8. PubMed ID: 463898 [TBL] [Abstract][Full Text] [Related]
12. Multiple dose activated charcoal for theophylline poisoning in young infants. Shannon M; Amitai Y; Lovejoy FH Pediatrics; 1987 Sep; 80(3):368-70. PubMed ID: 3627887 [TBL] [Abstract][Full Text] [Related]
13. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Ohning BL; Reed MD; Blumer JL Pediatr Pharmacol (New York); 1986; 5(4):241-5. PubMed ID: 3737269 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing the clinical efficacy of activated charcoal. Watson WA Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212 [TBL] [Abstract][Full Text] [Related]
15. Induced acute aflatoxicosis in goats: treatment with activated charcoal or dual combinations of oxytetracycline, stanozolol, and activated charcoal. Hatch RC; Clark JD; Jain AV; Weiss R Am J Vet Res; 1982 Apr; 43(4):644-8. PubMed ID: 6803625 [No Abstract] [Full Text] [Related]
16. Palatability of sucrose-, sorbitol-, and saccharin-sweetened activated charcoal formulations. Cooney DO Am J Hosp Pharm; 1980 Feb; 37(2):237-9. PubMed ID: 7361798 [TBL] [Abstract][Full Text] [Related]
17. [Use of activated charcoal for treatment of oral poisoning in Canada]. Obayashi A Chudoku Kenkyu; 2007 Jan; 20(1):65-6. PubMed ID: 17319504 [No Abstract] [Full Text] [Related]
18. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers. Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749 [TBL] [Abstract][Full Text] [Related]
19. Innovative approaches to the administration of activated charcoal in pediatric toxic ingestions. West L Pediatr Nurs; 1997; 23(6):616-9. PubMed ID: 9429522 [TBL] [Abstract][Full Text] [Related]
20. Effect of activated charcoal on acetaminophen absorption. Levy G; Houston JB Pediatrics; 1976 Sep; 58(3):432-5. PubMed ID: 958771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]